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0. Southwick, and J. Michael Fessel, Department of Surgery (Ortho-
pedics), Yale University School of Medicine.
Enzymatic degradation of ground substance is apparently involved in the
pathogenesis of cartilage erosion in osteoarthritis. Previous work in this
laboratory has provided evidence in favor of an enzyme, present in canine
and human cartilage, which can split sulfate from chondroitin sulfate."3
Papain and other proteolytic agents have been shown capable of splitting the
100
o \ 1% chondromucoproteinl





*- 70- plus plasmin
60- ,
0 30 60 90 120 150 180
Time in Minutes
FIG. 1. Effect of plasmin in reducing viscosity of chondromucoprotein. Relative
viscosity is measured in mixtures of 4 ml. of 1 per cent CMP plus 2 ml. neutral
saline-phosphate solution with and without 5,000 units of human plasmin. Readings
were made in a constant temperature water bath at 37° C. in 100 ml. Cannon-Fenski
viscosimeters, and represent the average of four separate determinations.
protein-chondroitin sulfate bonds.8 No similar mammalian enzymes in
joint tissues were found until Ziff, et al.' demonstrated an agent extracted
from the synovial membrane in cases of acute rheumatoid arthritis and
related this to its content of granulocytes. Since this type of inflammation
is not usually seen in osteoarthritis, it is of considerable interest that
Lack' has suggested blood plasmin as another possible agent which could
initiate digestion of the cartilage surface of a traumatized joint. He showed
that damaged human cartilage can activate plasminogen and that bovine
plasmin can digest bovine cartilage in vitro. On the other hand, Clifton5
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has used human plasmin clinically as a debriding agent in open wounds in-
volving joints and reports good results, with no adverse action on
articular cartilage. Our purpose was to investigate this paradox.
Purified chondromucoprotein (CMP) was prepared from calf nasal
cartilage7 and incubated with human plasmin** as illustrated in Figure 1.
This shows that human plasmin has marked viscosity-reducing action
in vitro against a major component of cartilage in its purified form.
However, repeated intra-articular injections of 5,000 units of plasmin
TABLE 1. EsTER SULFATE CONTENT OF HUMAN ARTICULAR AND COSTAL
CARTILAGE SLICES INCUBATED IN TYRODE'S SOLUTION
FOR 15 HOURS AT 370 C.
Expressed in mg.
S per 100 gm.
cartilage net weight Standard deviation
Initial value before incubation 350 31
Postincubation with 7,000 units of
human plasmin 305 43
Postincubation control 287 36
Each value represents the average of two samples of articular cartilage and four of
costal cartilage determined in quadruplicate.
twice weekly into the knee joints of six dogs and six rabbits for a
period of six or more weeks showed no changes in the articular cartilage.
Six more rabbits were subjected to surgical laceration of the lateral
capsules of the knee joints, and contusion of the cartilage surface of the
lateral femoral condyle with a bone punch. Again, repeated injections of
plasmin for six weeks produced no changes grossly or histologically when
compared with the controls. Also, slices of articular and costal cartilage
from groups of four rabbits, dogs and human patients were incubated
with 7,000 units of plasmin for 24 to 48 hours, at 37°C. with constant
agitation in various media (including oxygenated or non-oxygenated saline
or tris buffered saline or Tyrode's solution, under sterile conditions).
Though a little surface fraying was seen, no definite gross or microscopic
changes in the slices could be found.
Finally, normal human articular and costal cartilage slices were incubated
with and without 7,000 units of human plasmin, and analyzed for ester
sulfate by a method we have previously described.! As seen in Table 1,
** Human Fibrinolysin, courtesy of Merck, Sharpe and Dohme.
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both sets lost ester sulfate, but the control lost more than the plasmin-
treated strips. While part of this loss is from splitting of ester sulfate
itself,' electrophoresis of the two incubation media (0.05 ml. each on
Whatman #1 paper using acetate buffer at pH 4.3, room temperature,
1,000 volts for one hour, and stained when dry with toluidine blue) both
produce about equal metachromatic spots with the identical mobility of
chondroitin sulfate A. It is possible that the presence of antiplasmin or
other inhibitor,8 present in vivo or with the cartilage slices, prevented plas-
min from exerting destructive effects it is known to have on purified CMP.'
However, the electrophoretic results suggest that there may be in the
cartilage itself an agent which can split chondroitin sulfate bonds. This
possibility is now being investigated.
In conclusion, plasmin is not likely to be involved in the in vivo
degradation of CMP, and conversely, the use of plasmin as a debriding
agent in open wounds involving joints probably does not endanger articular
cartilage.
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